Daniel S Choi Ali Djalilian
10.1016/j.jaapos.2012.10.015
J AAPOS
2013 Feb;17(1):112-3.
author_manuscript
https://pubmed.ncbi.nlm.nih.gov/23360914/
Anti-Bacterial Agents / therapeutic use Azithromycin / therapeutic use Blepharitis / drug therapy Cyclosporine / therapeutic use Immunosuppressive Agents / therapeutic use Keratoconjunctivitis / drug therapy
Anti-Bacterial Agents / therapeutic use Azithromycin / therapeutic use Blepharitis / drug therapy Cyclosporine / therapeutic use Immunosuppressive Agents / therapeutic use Keratoconjunctivitis / drug therapy Case Reports Research Support, N.I.H., Extramural Administration, Oral Administration, Topical Anti-Bacterial Agents / administration & dosage Azithromycin / administration & dosage Child Child, Preschool Cyclosporine / administration & dosage Drug Therapy, Combination Humans Immunosuppressive Agents / administration & dosage Male Treatment Outcome Visual Acuity Anti-Bacterial Agents Immunosuppressive Agents Azithromycin Cyclosporine
PMC3703820
23360914
Oral azithromycin combined with topical anti-inflammatory agents in the treatment of blepharokeratoconjunctivitis in children
2013